img

Global Blue Eye Disease Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Blue Eye Disease Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
Blue Eye Disease Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Blue Eye Disease Vaccines market is projected to reach US$ 212.8 million in 2029, increasing from US$ 157.5 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Piglets and Adult Pigs are the major drivers for the industry.
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Blue Eye Disease Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Piglets
Adult Pigs

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Blue Eye Disease Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Blue Eye Disease Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Blue Eye Disease Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Blue Eye Disease Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Blue Eye Disease Vaccines introduction, etc. Blue Eye Disease Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Blue Eye Disease Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Blue Eye Disease Vaccines Market Overview
1.1 Blue Eye Disease Vaccines Product Overview
1.2 Blue Eye Disease Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Blue Eye Disease Vaccines Market Size by Type
1.3.1 Global Blue Eye Disease Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2024)
2 Global Blue Eye Disease Vaccines Market Competition by Company
2.1 Global Top Players by Blue Eye Disease Vaccines Sales (2018-2024)
2.2 Global Top Players by Blue Eye Disease Vaccines Revenue (2018-2024)
2.3 Global Top Players by Blue Eye Disease Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Blue Eye Disease Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blue Eye Disease Vaccines Market Competitive Situation and Trends
2.5.1 Blue Eye Disease Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Blue Eye Disease Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Blue Eye Disease Vaccines Market
2.8 Key Manufacturers Blue Eye Disease Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blue Eye Disease Vaccines Status and Outlook by Region
3.1 Global Blue Eye Disease Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blue Eye Disease Vaccines Historic Market Size by Region
3.2.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Blue Eye Disease Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Region
3.3.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Blue Eye Disease Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blue Eye Disease Vaccines by Application
4.1 Blue Eye Disease Vaccines Market Segment by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Blue Eye Disease Vaccines Market Size by Application
4.2.1 Global Blue Eye Disease Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2024)
5 North America Blue Eye Disease Vaccines by Country
5.1 North America Blue Eye Disease Vaccines Historic Market Size by Country
5.1.1 North America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blue Eye Disease Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Blue Eye Disease Vaccines Sales in Value by Country (2018-2024)
5.2 North America Blue Eye Disease Vaccines Forecasted Market Size by Country
5.2.1 North America Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
6 Europe Blue Eye Disease Vaccines by Country
6.1 Europe Blue Eye Disease Vaccines Historic Market Size by Country
6.1.1 Europe Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blue Eye Disease Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Blue Eye Disease Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Blue Eye Disease Vaccines Forecasted Market Size by Country
6.2.1 Europe Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Blue Eye Disease Vaccines by Region
7.1 Asia-Pacific Blue Eye Disease Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blue Eye Disease Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Blue Eye Disease Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Blue Eye Disease Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Blue Eye Disease Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blue Eye Disease Vaccines Sales in Value by Region (2024-2029)
8 Latin America Blue Eye Disease Vaccines by Country
8.1 Latin America Blue Eye Disease Vaccines Historic Market Size by Country
8.1.1 Latin America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blue Eye Disease Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Blue Eye Disease Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Blue Eye Disease Vaccines Forecasted Market Size by Country
8.2.1 Latin America Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Blue Eye Disease Vaccines by Country
9.1 Middle East and Africa Blue Eye Disease Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blue Eye Disease Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Blue Eye Disease Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Blue Eye Disease Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAHIC
10.1.1 CAHIC Company Information
10.1.2 CAHIC Introduction and Business Overview
10.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CAHIC Blue Eye Disease Vaccines Products Offered
10.1.5 CAHIC Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 MSD Animal Health Blue Eye Disease Vaccines Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Chopper Biology
10.4.1 Chopper Biology Company Information
10.4.2 Chopper Biology Introduction and Business Overview
10.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Chopper Biology Blue Eye Disease Vaccines Products Offered
10.4.5 Chopper Biology Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Ceva Blue Eye Disease Vaccines Products Offered
10.5.5 Ceva Recent Development
10.6 Ringpu Biology
10.6.1 Ringpu Biology Company Information
10.6.2 Ringpu Biology Introduction and Business Overview
10.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ringpu Biology Blue Eye Disease Vaccines Products Offered
10.6.5 Ringpu Biology Recent Development
10.7 Qilu Animal
10.7.1 Qilu Animal Company Information
10.7.2 Qilu Animal Introduction and Business Overview
10.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Qilu Animal Blue Eye Disease Vaccines Products Offered
10.7.5 Qilu Animal Recent Development
10.8 DHN
10.8.1 DHN Company Information
10.8.2 DHN Introduction and Business Overview
10.8.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 DHN Blue Eye Disease Vaccines Products Offered
10.8.5 DHN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blue Eye Disease Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blue Eye Disease Vaccines Industrial Chain Analysis
11.4 Blue Eye Disease Vaccines Market Dynamics
11.4.1 Blue Eye Disease Vaccines Industry Trends
11.4.2 Blue Eye Disease Vaccines Market Drivers
11.4.3 Blue Eye Disease Vaccines Market Challenges
11.4.4 Blue Eye Disease Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blue Eye Disease Vaccines Distributors
12.3 Blue Eye Disease Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Blue Eye Disease Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 5. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Blue Eye Disease Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Blue Eye Disease Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 9. Global Blue Eye Disease Vaccines Sales by Type (2024-2029) & (M Units)
Table 10. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Blue Eye Disease Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Blue Eye Disease Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Blue Eye Disease Vaccines Price by Type (2024-2029) & (USD/K Unit)
Table 14. North America Blue Eye Disease Vaccines Sales by Type (2018-2024) & (M Units)
Table 15. North America Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Blue Eye Disease Vaccines Sales (M Units) by Type (2018-2024)
Table 17. Europe Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Blue Eye Disease Vaccines Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Blue Eye Disease Vaccines Sales (M Units) by Type (2018-2024)
Table 21. Latin America Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Blue Eye Disease Vaccines Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Blue Eye Disease Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Blue Eye Disease Vaccines Sales by Company (2018-2024) & (M Units)
Table 25. Global Blue Eye Disease Vaccines Sales Share by Company (2018-2024)
Table 26. Global Blue Eye Disease Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Blue Eye Disease Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Blue Eye Disease Vaccines Price by Company (2018-2024) & (USD/K Unit)
Table 29. Global Blue Eye Disease Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Blue Eye Disease Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Blue Eye Disease Vaccines Market
Table 33. Key Manufacturers Blue Eye Disease Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Blue Eye Disease Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Blue Eye Disease Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Blue Eye Disease Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Blue Eye Disease Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 41. Global Blue Eye Disease Vaccines Sales by Region (2024-2029) & (M Units)
Table 42. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Blue Eye Disease Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Blue Eye Disease Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2024-2029)
Table 46. Global Blue Eye Disease Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Blue Eye Disease Vaccines Sales by Application (2018-2024) & (M Units)
Table 48. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Blue Eye Disease Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 52. Global Blue Eye Disease Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Blue Eye Disease Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Blue Eye Disease Vaccines Price by Application (2024-2029) & (USD/K Unit)
Table 57. North America Blue Eye Disease Vaccines Sales by Application (2018-2024) (M Units)
Table 58. North America Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Blue Eye Disease Vaccines Sales by Application (2018-2024) (M Units)
Table 60. Europe Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Blue Eye Disease Vaccines Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Blue Eye Disease Vaccines Sales by Application (2018-2024) (M Units)
Table 64. Latin America Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Blue Eye Disease Vaccines Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Blue Eye Disease Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 68. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Blue Eye Disease Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Blue Eye Disease Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 72. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Blue Eye Disease Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Blue Eye Disease Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 76. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Blue Eye Disease Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 80. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Blue Eye Disease Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Blue Eye Disease Vaccines Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Blue Eye Disease Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Blue Eye Disease Vaccines Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Blue Eye Disease Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Blue Eye Disease Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Blue Eye Disease Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. CAHIC Company Information
Table 108. CAHIC Introduction and Business Overview
Table 109. CAHIC Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. CAHIC Blue Eye Disease Vaccines Product
Table 111. CAHIC Recent Development
Table 112. Boehringer Ingelheim Company Information
Table 113. Boehringer Ingelheim Introduction and Business Overview
Table 114. Boehringer Ingelheim Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Boehringer Ingelheim Blue Eye Disease Vaccines Product
Table 116. Boehringer Ingelheim Recent Development
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Introduction and Business Overview
Table 119. MSD Animal Health Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. MSD Animal Health Blue Eye Disease Vaccines Product
Table 121. MSD Animal Health Recent Development
Table 122. Chopper Biology Company Information
Table 123. Chopper Biology Introduction and Business Overview
Table 124. Chopper Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Chopper Biology Blue Eye Disease Vaccines Product
Table 126. Chopper Biology Recent Development
Table 127. Ceva Company Information
Table 128. Ceva Introduction and Business Overview
Table 129. Ceva Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Ceva Blue Eye Disease Vaccines Product
Table 131. Ceva Recent Development
Table 132. Ringpu Biology Company Information
Table 133. Ringpu Biology Introduction and Business Overview
Table 134. Ringpu Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. Ringpu Biology Blue Eye Disease Vaccines Product
Table 136. Ringpu Biology Recent Development
Table 137. Qilu Animal Company Information
Table 138. Qilu Animal Introduction and Business Overview
Table 139. Qilu Animal Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Qilu Animal Blue Eye Disease Vaccines Product
Table 141. Qilu Animal Recent Development
Table 142. DHN Company Information
Table 143. DHN Introduction and Business Overview
Table 144. DHN Blue Eye Disease Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. DHN Blue Eye Disease Vaccines Product
Table 146. DHN Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Blue Eye Disease Vaccines Market Trends
Table 150. Blue Eye Disease Vaccines Market Drivers
Table 151. Blue Eye Disease Vaccines Market Challenges
Table 152. Blue Eye Disease Vaccines Market Restraints
Table 153. Blue Eye Disease Vaccines Distributors List
Table 154. Blue Eye Disease Vaccines Downstream Customers
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Blue Eye Disease Vaccines Product Picture
Figure 2. Global Blue Eye Disease Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Blue Eye Disease Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Blue Eye Disease Vaccines Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Blue Eye Disease Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Blue Eye Disease Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Blue Eye Disease Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Blue Eye Disease Vaccines Revenue in 2022
Figure 23. Blue Eye Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Piglets
Figure 25. Global Piglets Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of Adult Pigs
Figure 27. Global Adult Pigs Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Blue Eye Disease Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Blue Eye Disease Vaccines Sales Market Share by Application in 2022 & 2029
Figure 30. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Blue Eye Disease Vaccines Manufacturing Cost Structure
Figure 41. Blue Eye Disease Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries